The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...

Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...

The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Fresenius Kabi will be fully responsible for the marketing of Vifor’s intravenous iron portfolio in China.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Learn more Any adventure duffel worth its weight is tough. Durability is one of many reasons people love the Black Hole and Base Camp, two iconic bags from Patagonia and The North Face. From afar, the ...

When you buy through our links, we may earn a commission. Learn more› By Kit Dillon Kit Dillon is a writer focused on bags and travel gear. He has worked for Wirecutter for a decade and lost ...

Amicus™ high collection efficiency yields multiple products per donor for the lowest-cost platelet production. It is designed to adapt to the requirements of different collection settings. Let ...

1 Day FRE -2.26% DJIA 0.26% S&P 500 0.33% Health Care/Life Sciences 1.32% ...